RIFAXIMIN | N021361 | SALIX PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
SALIX PHARMACEUTICALS, INC. et al v. AJANTA PHARMA LTD. et al 3 patentsANDA 220990rifaximin | D.N.J. | 2025-11-20 | Terminated 2026-01-13 | — |
SALIX PHARMACEUTICALS, INC. et al v. ALKEM LABORATORIES LTD. 3 patentsANDA 220451rifaximin | D.N.J. | 2025-06-10 | Terminated 2025-08-14 | — |
SALIX PHARMACEUTICALS, INC. et al v. SABA ILAC SANAYI VE TICARET A.S. 4 patentsANDA 219940rifaximin | D.N.J. | 2025-04-04 | Terminated 2025-09-15 | — |
Salix Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals, Inc. 3 patentsANDA 219687rifaximin | WVND | 2025-03-26 | Terminated 2025-10-02 | — |
SALIX PHARMACEUTICALS, INC. et al v. CIPLA USA, INC. et al 3 patentsANDA 219570rifaximin | D.N.J. | 2024-11-01 | Terminated 2025-10-21 | — |
SALIX PHARMACEUTICALS, INC. et al v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC et al 8 patentsANDA 218862rifaximin | D.N.J. | 2024-04-05 | Active | — |
Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. 23 patentsANDA 214369rifaximin | D. Del. | 2020-03-26 | Terminated 2022-08-10 | — |
| D.N.J. | 2019-09-30 | Terminated 2020-05-12 | — | |
Salix Pharmaceuticals Ltd. et al v. Sun Pharmaceuticals Industries Ltd. 14 patentsANDA 213042rifaximin | D. Del. | 2019-04-24 | Terminated 2020-09-25 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).